UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients

Anesthesiology (Philadelphia), 2006-01, Vol.104 (1), p.21-26

2006

Volltextzugriff (PDF)

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

Pharmacogenetics and genomics, 2006-02, Vol.16 (2), p.101-110

2006

Volltextzugriff (PDF)

Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

Clinical infectious diseases, 2006-02, Vol.42 (3), p.401-407

2006

Volltextzugriff (PDF)

Associations between CYP2B6 Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans

The Journal of infectious diseases, 2009-03, Vol.199 (6), p.872-880

2009

Volltextzugriff (PDF)

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects

Clinical pharmacology and therapeutics, 2003-01, Vol.73 (1), p.41-50

2003

Volltextzugriff (PDF)

Pharmacogenetics of Nevirapine-Associated Hepatotoxicity: An Adult AIDS Clinical Trials Group Collaboration

Clinical infectious diseases, 2006-09, Vol.43 (6), p.783-786

2006

Volltextzugriff (PDF)

Pharmacogenetics of Long-Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study

The Journal of infectious diseases, 2005-12, Vol.192 (11), p.1931-1942

2005

Volltextzugriff (PDF)

Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier

The Journal of pharmacology and experimental therapeutics, 2006-06, Vol.317 (3), p.1012-1018

2006

Volltextzugriff (PDF)

Tariquidar, a Selective P-glycoprotein Inhibitor, Does Not Potentiate Loperamide's Opioid Brain Effects in Humans despite Full Inhibition of Lymphocyte P-glycoprotein

Anesthesiology (Philadelphia), 2008-12, Vol.109 (6), p.1092-1099

2008

Volltextzugriff (PDF)

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study

AIDS (London), 2004-12, Vol.18 (18), p.2391-2400

2004

Volltextzugriff (PDF)

New up-conversion luminescence in molecular cyano-substituted naphthylsalophen lanthanide() complexes

Chemical communications (Cambridge, England), 2021-03, Vol.57 (2), p.2551-2554

2021

Volltextzugriff (PDF)

Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study

Pharmacogenetics and genomics, 2006-11, Vol.16 (11), p.837-845

2006

Volltextzugriff (PDF)

Drug Metabolism and Variability among Patients in Drug Response

The New England journal of medicine, 2005-05, Vol.352 (21), p.2211-2221

Wilkinson, Grant R

2005

Volltextzugriff (PDF)

CYP3A activity in European American and Japanese men using midazolam as an in vivo probe

Clinical pharmacology and therapeutics, 2001-05, Vol.69 (5), p.333-339

2001

Volltextzugriff (PDF)

Identification of functionally variant MDR1 alleles among European Americans and African Americans

Clinical pharmacology and therapeutics, 2001-08, Vol.70 (2), p.189-199

2001

Volltextzugriff (PDF)

OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine

Drug metabolism and disposition, 1999-08, Vol.27 (8), p.866

1999

Volltextzugriff (PDF)

Sedative Plasma Concentrations and Delirium Risk in Critical Illness

The Annals of pharmacotherapy, 2018-06, Vol.52 (6), p.513-521

2018

Volltextzugriff (PDF)

Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity

Clinical pharmacology and therapeutics, 1994-10, Vol.56 (4), p.359-367

1994

Volltextzugriff (PDF)

Inhibition of P-glycoprotein-mediated drug transport : A unifying mechanism to explain the interaction between digoxin and quinidine

Circulation (New York, N.Y.), 1999-02, Vol.99 (4), p.552-557

1999

Volltextzugriff (PDF)

Genetic variability in CYP3A5 and its possible consequences

Pharmacogenomics, 2004-04, Vol.5 (3), p.243-272

2004

Volltextzugriff (PDF)

Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes

Drug metabolism and disposition, 2000-06, Vol.28 (6), p.655

2000

Volltextzugriff (PDF)

Population differences in S‐warfarin metabolism between CYP2C9 genotype‐matched Caucasian and Japanese patients

Clinical pharmacology and therapeutics, 2003-03, Vol.73 (3), p.253-263

2003

Volltextzugriff (PDF)

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

Clinical pharmacology and therapeutics, 2006-09, Vol.80 (3), p.228-234

2006

Volltextzugriff (PDF)

Identification and Functional Characterization of a New CYP2C9 Variant (CYP2C95) Expressed among African Americans

Molecular pharmacology, 2001-08, Vol.60 (2), p.382-387

2001

Volltextzugriff (PDF)

Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein

Pharmaceutical research, 1999-03, Vol.16 (3), p.408-414

1999

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Englisch
(227)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Life Sciences & Biomedicine
(163)
Humans
(148)
Male
(101)
Biological And Medical Sciences
(82)
Pharmacology & Pharmacy
(81)
Medical Sciences
(76)
Adult
(74)
Female
(71)
Pharmacology. Drug Treatments
(54)
Middle Aged
(49)
Aged
(34)
Animals
(27)
Cytochrome P-450 Enzyme System - Metabolism
(24)
Aryl Hydrocarbon Hydroxylases
(23)
Cytochrome P-450 Enzyme System - Genetics
(21)
General Pharmacology
(21)
Kinetics
(21)
Phenotype
(21)
Half-Life
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

Associations between CYP2B6 Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects

Pharmacogenetics of Nevirapine-Associated Hepatotoxicity: An Adult AIDS Clinical Trials Group Collaboration

Pharmacogenetics of Long-Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study

Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier

Tariquidar, a Selective P-glycoprotein Inhibitor, Does Not Potentiate Loperamide's Opioid Brain Effects in Humans despite Full Inhibition of Lymphocyte P-glycoprotein

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study

New up-conversion luminescence in molecular cyano-substituted naphthylsalophen lanthanide() complexes

Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study

Drug Metabolism and Variability among Patients in Drug Response

CYP3A activity in European American and Japanese men using midazolam as an in vivo probe

Identification of functionally variant MDR1 alleles among European Americans and African Americans

OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine

Sedative Plasma Concentrations and Delirium Risk in Critical Illness

Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity

Inhibition of P-glycoprotein-mediated drug transport : A unifying mechanism to explain the interaction between digoxin and quinidine

Genetic variability in CYP3A5 and its possible consequences

Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes

Population differences in S‐warfarin metabolism between CYP2C9 genotype‐matched Caucasian and Japanese patients

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

Identification and Functional Characterization of a New CYP2C9 Variant (CYP2C95) Expressed among African Americans

Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein

Suchergebnisse filtern